Research Article

Safety Assessment of Zigbir®: A Polyherbal Formulation in Sprague-Dawley Rats

Table 8

Relative organ weights (% of fasting body weight; mean ± SD) in male rats treated with Zigbir® orally for 90 days.

OrganControl250 mg/kg500 mg/kg1000 mg/kgControl recovery1000 mg/kg recovery

Terminal body weight (g)348.86 ± 18.31342.77 ± 28.01332.90 ± 24.41339.11 ± 32.83367.32 ± 29.61347.08 ± 37.86
Brain 0.568 ± 0.0270.574 ± 0.0390.571 ± 0.0270.583 ± 0.0600.536 ± 0.0420.582 ± 0.056
Liver3.331 ± 0.3033.077 ± 0.2803.083 ± 0.5363.033 ± 0.3842.412 ± 0.5682.792 ± 0.570
Kidneys0.743 ± 0.0760.730 ± 0.0580.711 ± 0.0630.739 ± 0.0430.676 ± 0.1070.752 ± 0.139
Adrenals 0.0148 ± 0.0030.0174 ± 0.0030.0169 ± 0.0020.0155 ± 0.0030.0159 ± 0.0030.0151 ± 0.003
Testes0.829 ± 0.0630.830 ± 0.0940.906 ± 0.1240.849 ± 0.1160.725 ± 0.1030.835 ± 0.179
Heart0.324 ± 0.0260.306 ± 0.0160.298 ± 0.0280.298 ± 0.0270.271 ± 0.0310.308 ± 0.044
Spleen 0.301 ± 0.0620.331 ± 0.1050.359 ± 0.0980.349 ± 0.0630.300 ± 0.0990.341 ± 0.040
Lungs0.461 ± 0.0680.518 ± 0.0670.478 ± 0.1020.479 ± 0.0620.411 ± 0.0950.386 ± 0.181